Author:
Askarian Farahnaz,Ghorbanihaghjo Amir,Argani Hassan,Sanajou Davoud,Nasehi Nima,Askarian Roya,Ahmadi Ravan,Rahtchizadeh Nadereh
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Karohl C, Raggi P. Approach to cardiovascular disease prevention in patients with chronic kidney disease. Curr Treat Options Cardiovasc Med. 2012;14(4):391–413.
2. Liu M, Li X, Lu L, Cao Y, Sun R, Chen S, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918–26.
3. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int. 2002;62(5):1791–8.
4. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.
5. Winkles JA. The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008;7(5):411–25.